SCHEMBL6003099

SCHEMBL6003099

CC(C)(C)OC(=O)/C=C(/Br)C(=O)OC(C)(C)C

nearest known ligand 0.31

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
DGAT1 O75907 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4250295 1.00 DGAT1 (0.31) DGAT1
SCHEMBL4250292 1.00 DGAT1 (0.31) DGAT1
SCHEMBL29092146 0.80 DGAT1 (0.32) DGAT1
SCHEMBL4254464 0.74 DGAT1 (0.31) DGAT1
SCHEMBL4254502 0.74 DGAT1 (0.31) DGAT1
SCHEMBL6002981 0.74 DGAT1 (0.31) DGAT1
SCHEMBL4254614 0.74 DGAT1 (0.31) DGAT1
SCHEMBL4254507 0.74 DGAT1 (0.31) DGAT1
SCHEMBL4254470 0.74 DGAT1 (0.31) DGAT1
SCHEMBL2243161 0.72 DGAT1 (0.30) DGAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL DGAT1 2609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.